SCSHP Annual Meeting 2020 (Pharmacists)

Date: Mar 12, 2020 08:00 AM - Mar 13, 2020 05:45 PM
Fee
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
Accreditation(s)
Requirements for CE Credit
- Check in upon arrival at the meeting
- Complete and submit the "CE Sign In" form at the meeting
- Complete the online program evaluations
- Provide the correct month and day of birth and NABP e-Profile ID. Registration with a proper disclosure of your NABP E-Profile ID is a requirement for receiving Continuing Pharmacy Education. To register with or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.
SCSHP Annual Meeting 2020 (Pharmacists)
Thu, Mar 12, 2020
Impact of Clinician Burnout on Patient Safety: Journey to a Resilient & Thriving Healthcare Workforce
- Define burnout, well-being, and resilience
- Explain why clinician burnout is a patient care and healthcare workforce problem
- Discuss the U.S. National Academy of Medicine Clinician Well-Being and Resilience Action Collaborative and consensus study
- Identify strategies to improve well-being and resilience in the healthcare workforce
Speaker(s)/Author(s)
|
Paul W. Abramowitz, Pharm.D., Sc.D. (Hon), FASHP
|
Activity Number
0062-9999-20-084-L04-PCE Hours
Beyond Diversity and Inclusion 101
- Recognize that diversity promotes healthier leadership and decision-making
- Define implicit biases and their pervasiveness
- Examine the impact of mitigating implicit bias on decisions in healthcare and education
Speaker(s)/Author(s)
|
B. DaNine Fleming, EdS, EdD
|
Activity Number
0062-9999-20-085-L04-PCE Hours
Top 10 Infectious Diseases Topics of 2019
- Apply updated infectious diseases treatment guidelines and policies to antimicrobial recommendations
- Analyze clinical implications of peer-reviewed infectious diseases literature
- Determine the role of newly approved antimicrobials
- Acknowledge emerging pathogens both nationally and globally
- Discuss changes in roles and responsibilities of pharmacists in managing infectious diseases
Speaker(s)/Author(s)
|
P. Brandon Bookstaver, PharmD, FCCP, BCIDP
|
Activity Number
0062-9999-20-086-L01-PCE Hours
Teaching Points from a Family Medicine Rounding Service
- Identify patients who would be appropriate candidates for high-dose intravenous thiamine replacement
- Recognize when a short-course corticosteroid regimen may require a taper
- Explain the unreliability of subgroup analyses
Speaker(s)/Author(s)
|
Kathryn Rice, PharmD, BCPS
|
Activity Number
0062-9999-20-087-L01-PCE Hours
To “Heart” Fail or Not? The Question regarding SGLT-2 inhibitors
- Explain the mechanism of action for sodium glucose co-transporter 2 (SGLT-2) inhibitors
- Critically evaluate the published literature regarding SGLT-2 inhibitors on heart failure (HF) outcomes
- Formulate a treatment regimen with a SGLT-2 inhibitor for a patient with type 2 diabetes mellitus (T2DM) and HF
Speaker(s)/Author(s)
|
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
|
Activity Number
0062-9999-20-088-L01-PCE Hours
Clinical Pharmacy Challenge: Part 1
- Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
- Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
- Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions
Speaker(s)/Author(s)
|
P. Brandon Bookstaver, PharmD, FCCP, BCIDP
|
Activity Number
0062-9999-20-089-L01-PCE Hours
Platform Presentations: 2020
- Effect of pharmacist-led educational interventions on proton pump inhibitor de-prescribing in an inpatient psychiatric facility – Anju Balani, PharmD Candidate, Presbyterian College School of Pharmacy
- Cyclin-dependent kinase 8/19 inhibitors suppress the metastatic growth of secondary tumor cells ex vivo – Stephan Bowe, PharmD Candidate, USC College of Pharmacy
- Comparative Monte Carlo analysis of cefepime/VNRX-5133 and meropenem/vaborbactam against resistant Gram-negative pathogens – Meghan White, PharmD Candidate, MUSC College of Pharmacy
- Discuss emerging research outcomes from throughout the state of South Carolina
- Recognize novel ideas for research and quality initiative projects in your pharmacy practice areas
- Review pivotal results from local investigations across the state of South Carolina
Activity Number
0062-9999-20-090-L04-PCE Hours
Clinical Pharmacy Challenge: Part 2
- Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
- Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
- Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions
Speaker(s)/Author(s)
|
P. Brandon Bookstaver, PharmD, FCCP, BCIDP
|
Activity Number
0062-9999-20-091-L01-PCE Hours
Fri, Mar 13, 2020
Combating the Opioid Crisis in South Carolina
- Review the history of opioid use and the impact of the current opioid epidemic in the U.S.
- Discuss pain management strategies that health care practitioners can use in light of the opioid epidemic
- Review the path to opioid use disorder (OUD) and key preventative strategies that everyone can employ to reduce the risk of opioid overdose
Speaker(s)/Author(s)
|
Doug Furmanek, PharmD, BCCP
|
Activity Number
0062-9999-20-095-L08-PCE Hours
Bloody Hell!! Updates in the Treatment of Bloodstream Infections
- Evaluate the role of newer, carbapenem-sparing agents for the treatment of resistant Gram-negative bloodstream infections (BSI)
- Identify and assess candidates for shorter durations of therapy for BSIs
- Evaluate and apply recent literature for oral antibiotics in BSIs
Speaker(s)/Author(s)
|
Krutika N. Mediwala, PharmD, BCPS, BCIDP
|
Activity Number
0062-9999-20-096-L01-PCE Hours
Pharmacist Code Response: ACLS and Beyond
- Demonstrate knowledge of Advanced Cardiac Life Support (ACLS) algorithms per the American Heart Association (AHA) guidelines
- Discuss the evidence behind interventions in cardiac arrest and determine which interventions are most likely to positively impact patient outcomes
- Describe the possible future of cardiac arrest care based on emerging evidence
Speaker(s)/Author(s)
|
Elizabeth Robinette, PharmD, BCCCP
|
Activity Number
0062-9999-20-097-L01-PCE Hours
Should What's Old Be New Again?: Old Drugs Repurposed for Septic Shock
- Describe the mechanisms of action for ascorbic acid, thiamine, and angiotensin II for the treatment of septic shock
- List the possible pros and cons of using ascorbic acid, thiamine, and angiotensin II for a patient with septic shock
- Design appropriate monitoring parameters when prescribed ascorbic acid, thiamine, and angiotensin II, given a patient in septic shock
Speaker(s)/Author(s)
|
Carolyn A. Magee, PharmD, BCCCP
|
Activity Number
0062-9999-20-098-L01-PCE Hours
Resident Rapid Fire, Part 1
- Determine the appropriate duration of therapy for community-acquired pneumonia (CAP)?
- Summarize the evidence regarding duration of therapy for CAP
- Define gestational hypertension, preeclampsia and HELLP
- Identify the most common risk factors for preeclampsia
- Review current guidelines and literature for the utilization of the MRSA-PCR nasal swab
- Identify appropriate non-respiratory related illnesses in which MRSA-PCR nasal swab can be utilized to guide antibiotic therapy
Speaker(s)/Author(s)
|
Jasmine E. Manning, MPH, PharmD
|
|
|
Rebecca Howell, PharmD, RN
|
|
|
Robin Fischer, PharmD
|
Activity Number
0062-9999-20-099-L01-PCE Hours
Resident Rapid Fire, Part 2
- Recommend low-dose insulin regimens for high-risk patients with hyperkalemia
- Evaluate the potential role of potassium binders in the emergent treatment of hyperkalemia
- Identify the current available preventative migraine treatment options
- Evaluate the literature available for erenumab to determine its place in therapy
- Determine the appropriate utilization of continuous glucose monitoring in diabetes care.
- Discuss thromboelastography (TEG) use and the interpretation of results in the setting of hemorrhage
Speaker(s)/Author(s)
|
Hannah Green, PharmD
|
|
|
Kennedy Gambill, PharmD
|
|
|
Melanie Routhieaux, PharmD, BCPS
|
|
|
Reaghan Erickson, PharmD
|
Activity Number
0062-9999-20-100-L01-PCE Hours
Precepting is a lot: tips and tools from a drug information faculty member
- Identify drug information topics and resources taught in didactic pharmacy curricula
- Recognize common learning theories
- Discover methodologies utilized on a successful rotation
- Utilize available tools to maintain a current pharmacy knowledge base
Speaker(s)/Author(s)
|
Christopher S. Wisniewski, PharmD, MSCR, BCPS
|

